ClinVar Miner

Submissions for variant NM_001039958.2(MESP2):c.307G>T (p.Glu103Ter)

dbSNP: rs71647808
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000760454 SCV000890340 pathogenic not provided 2018-06-12 criteria provided, single submitter clinical testing The E103X variant in the MESP2 gene has been reported previously as a founder variant in the Puerto Rican population and has been observed frequently in the homozygous and compound heterozygous states in individuals with spondylothoracic dysostosis (STD) (Cornier et al., 2008). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The E103X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret E103X as a pathogenic variant.
Invitae RCV000760454 SCV000947457 pathogenic not provided 2024-01-31 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Glu103*) in the MESP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MESP2 are known to be pathogenic (PMID: 9242490, 18485326). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with spondylocostal dysostosis (PMID: 18485326). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5184). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000005493 SCV000025675 pathogenic Spondylocostal dysostosis 2, autosomal recessive 2008-06-01 no assertion criteria provided literature only
GeneReviews RCV000005493 SCV000055731 pathologic Spondylocostal dysostosis 2, autosomal recessive 2010-08-05 no assertion criteria provided curation Converted during submission to Pathogenic.
Natera, Inc. RCV000005493 SCV001454605 pathogenic Spondylocostal dysostosis 2, autosomal recessive 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.